TVRD
NASDAQ · Pharmaceuticals
Tvardi Therapeutics Inc
$1.71
+0.10 (+6.21%)
Open$1.63
Previous Close$1.61
Day High$1.73
Day Low$1.62
52W High$43.65
52W Low$1.50
Volume—
Avg Volume123.7K
Market Cap21.61M
P/E Ratio—
EPS$-2.78
SectorPharmaceuticals
Analyst Ratings
Strong Buy
14 analysts
Price Target
+2,126.3% upside
Current
$1.71
$1.71
Target
$38.07
$38.07
$23.38
$38.07 avg
$43.34
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 62.21M | 91.89M | 10.81M |
| Net Income | -617,720,334 | -821,193,944 | 2.98M |
| Profit Margin | -993.0% | -943.3% | 27.6% |
| EBITDA | -570,311,584 | -800,289,519 | 3.89M |
| Free Cash Flow | — | — | 2.37M |
| Rev Growth | -32.3% | -32.3% | +19.2% |
| Debt/Equity | — | — | 0.91 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |